Nipah virus encephalitis medical therapy
|
Nipah virus encephalitis Microchapters |
|
Differentiating Nipah virus encephalitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nipah virus encephalitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Nipah virus encephalitis medical therapy |
|
Risk calculators and risk factors for Nipah virus encephalitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
The distribution of these agents in their natural reservoirs will eventually define the geographic range of the threat the viruses pose. However, these viruses are recent discoveries, and much work remains to be done on their geographic distribution and the reservoir species. The occurrence of the disease in humans has been associated only with infection of an intermediate species such as horses with Hendra and swine with Nipah virus. Early recognition of the disease in the intermediate animal host is probably the most crucial means of limiting future human cases.
Pharmacotherapy
The drug ribavirin has been shown to be effective against the viruses in vitro. However, controlled drug investigations have not been performed and the clinical usefulness of these drugs is uncertain.